Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign a consent form agreeing to take part in the trial
- Women between 18 and 70 years of age
- People who have been newly diagnosed with breast cancer on the left side, confirmed by a tissue sample test
- People who have no signs that the cancer has spread to other parts of the body
- People who are scheduled to have either a full mastectomy (removal of the breast) or breast-conserving surgery (removal of only part of the breast)
- People who are reasonably well and able to carry out daily activities, based on a standard medical assessment scale (confirm with trial site)
- People whose body is able to tolerate radiation treatment
- People whose planned radiation treatment area covers the left breast or chest wall, with or without nearby lymph node areas
Who may not be able to join:
- People who had cancer in both breasts at the time of diagnosis
- People who have previously had breast reconstruction or a breast implant on the affected side
- People who have previously received radiation treatment to the chest or the area above the collarbone
- People who the trial doctor considers unsuitable for the study for medical or other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13189092896
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Radiotherapy Planning Dose-Volume Parameter -Volume of 5Gy heart dose; Radiotherapy Planning Dose-Volume Parameter -Max dose of LAD; Radiotherapy Planning Dose-Volume Parameter -mean heart dose; Major Cardiovascular Events; Subclinical Cardiovascular Events- Left ventricular ejection fraction (LVEF); Subclinical Cardiovascular Events- Left ventricular diastolic dysfunction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.